logo
Share SHARE
FONT-SIZE Plus   Neg

Lupin Launches Generic Tricor Tablets In US

Pharma major Lupin Ltd., said its subsidiary Lupin Pharmaceuticals Inc. had launched its Fenofibrate tablets in 48 mg and 145 mg strengths in the US, for which it had received final approval from the US FDA.

Lupin's Fenofibrate tablets are the AB rated generic equivalent of Abbott's Tricor tablets and are indicated for primary hypercholesterolemia or mixed dyslipidemia and severe hypertriglyceridemia.

Abbott's Tricor tables, 48 mg and 145 mg, had sales of $1.26 billion as per IMS Health, June 2012.

Commenting on the approval, Lupin Pharmaceuticals CEO and Group President Vinita Gupta said, "We are very happy to bring this product to market in the US. Patients can be assured that they are receiving the same high quality product they have been accustomed to a a more affordable price."

At the BSE, Lupin shares are currently trading at Rs.565.50, up 0.60 percent from the previous close.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Succumbing to competition from the latest smartphones, BlackBerry has decided to shut down its phone making business. Once a market leader and a highly preferred phone maker, BlackBerry's products were highly praised for its security features and ergonomic designs. In fear of hard plastic contamination in cooked chicken nuggets, Tyson Foods has voluntarily recalled more than 132 thousand pounds of fully cooked nuggets. Wells Fargo's two former employees have filed a lawsuit against the bank, seeking $2.6 billion, on behalf of employees affected amid the unauthorized accounts scandal. The plaintiffs are seeking class-action status for the lawsuit. Former employees Alexander Polonsky and Brian Zaghi accuse Wells Fargo of wrongful termination.
comments powered by Disqus
Follow RTT